news
We are thrilled to announce that Diadem Biotherapeutics has been selected as the winner and recipient of the first Amgen Golden Ticket Award at BioLabs LA!
Awarded 1st AMGEN Golden Ticket
August 2021
With lead investment from Novateur Ventures, Diadem Biotherapeutics raised $1.2 million to develop first- and best-in class immunotherapies, bringing us one step closer to developing cures for patients worldwide.
Raised $1.2 million
July 2021
May 2021
Diadem Biotherapeutics is officially a Creative Destruction Lab graduate, successfully completing nine months of objective based startup mentorship!
Creative Destruction Lab
November 2019
Diadem Biotherapeutics is thrilled to join the world’s leading biotechnology startup accelerator program IndieBio in San Francisco, CA!
IndieBio Batch 9
September 2019
Diadem Biotherapeutics is honored to have been selected to pitch at the 2019 QB3 Biotech/Biopharma Pitch Summit!